Rating Change
William Blair analysts initiated coverage on Edgewise Therapeutics, Inc. Common Stock (NASDAQ:EWTX) with a rating of Outperform on October 16, 2026.
new coverageNASDAQ:EWTX
William Blair Initiates Coverage on Edgewise Therapeutics, Inc. Common Stock (EWTX) with Outperform
William Blair analysts initiated coverage on Edgewise Therapeutics, Inc. Common Stock (NASDAQ:EWTX) with a rating of Outperform on October 16, 2026.
At publication ·
What changed
Edgewise Therapeutics, Inc. Common Stock (NASDAQ:EWTX) · new coverage
- Firm
- William Blair
- Rating
- Outperform
- Price at event
- $37.19
- Market capitalization
- $2.5B
At a glance
Key takeaways
- William Blair initiated coverage of Edgewise Therapeutics (EWTX) with an Outperform rating on October 16, 2026.
- EWTX trades at $37.19 with a market capitalization of $2.5 billion in the healthcare sector.
Market Context
Edgewise Therapeutics, Inc. Common Stock operates in the Healthcare sector. The stock currently trades at $37.19 with a market capitalization of $2.5B.
Analyst coverage from William Blair provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Edgewise Therapeutics, Inc. Common Stock.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Edgewise Therapeutics, Inc. Common Stock
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 16, 2026 | William Blair | Outperform | N/A |
| Sep 21, 2026 | HC Wainwright & Co. | Buy | N/A |
| Aug 20, 2026 | JP Morgan | Overweight | N/A |
| Aug 11, 2026 | Goldman Sachs | Neutral | N/A |
| Jul 20, 2026 | Evercore ISI Group | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View EWTX Stock Page
Frequently Asked Questions
What does the Outperform rating mean for EWTX?
A rating of Outperform from William Blair reflects the analyst's outlook on Edgewise Therapeutics, Inc. Common Stock (NASDAQ:EWTX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the EWTX forecast page.
